Analytical methods for psychoactive N,N-dialkylated tryptamines

TrAC - Trends in Analytical Chemistry

Volumn 29, Issue 8, 2010, Pages 858-869

  Brandt, Simon D ^a   Martins, Cláudia P B ^b  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^b Thermo Fisher Scientific   (United States)

Author keywords

Capillary electrophoresis; Clinical; Derivative; Forensic; Gas chromatography; Hallucinogen; High performance liquid chromatography; N,N dialkylated tryptamine; Pharmaceutical; Psychoactivity

Indexed keywords

CAPILLARY ELECTROPHORESIS; DERIVATIVES; DRUG PRODUCTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; POLYCYCLIC AROMATIC HYDROCARBONS;

CLINICAL; FORENSIC; HALLUCINOGEN; PSYCHOACTIVITY; TRYPTAMINES;

GAS CHROMATOGRAPHY;

4 ACETOXY N METHYL N ISOPROPYLTRYPTAMINE; 4 ACETOXY N,N DIISOPROPYLTRYPTAMINE; 4 HYDROXY N METHYL N ISOPROPYLTRYPTAMINE; 4 HYDROXY N,N DIISOPROPYLTRYPTAMINE; 4 HYDROXY N,N DIPROPYLTRYPTAMINE; ALPHA METHYLTRYPTAMINE; BUFOTENINE; ETHYLAMINE; HYDROGEN; INDOLE; N ETHYL N ISOPROPYLTRYPTAMINE; N ETHYL N PROPYLTRYPTAMINE; N METHYL N CYANOMETHYLTRYPTAMINE; N METHYL N ETHYLTRYPTAMINE; N METHYL N ISOBUTYLTRYPTAMINE; N METHYL N ISOPROPYLTRYPTAMINE; N METHYL N PROPYLTRYPTAMINE; N,N DIALKYLATED TRYPTAMINE; N,N DIBUTYLTRYPTAMINE; N,N DIETHYLTRYPTAMINE; N,N DIISOBUTYLTRYPTAMINE; N,N DIISOPROPYLTRYPTAMINE; N,N DIMETHYLTRYPTAMINE; N,N DIPROPYLTRYPTAMINE; NATURAL PRODUCT; PSILOCIN; PSILOCYBINE; PSYCHEDELIC AGENT; PSYCHOTROPIC AGENT; TRYPTAMINE DERIVATIVE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; CAPILLARY ELECTROPHORESIS; CHEMICAL STRUCTURE; CONSCIOUSNESS; CONSUMER; DERIVATIZATION; GAS CHROMATOGRAPHY; HEALTH CARE PERSONNEL; MEDICAL INFORMATION; PRIORITY JOURNAL; PUBLICATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; REVIEW; SCIENTIST;

EID: 77955662264     PISSN: 01659936     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trac.2010.04.008     Document Type: Review

References (56)

1. Shulgin A.T., Shulgin A. TIHKAL: The Continuation 1997, Transform Press, Berkeley, CA, USA.
2. Strassman R.J. Behav. Brain Res. 1996, 73:121.
3. Shulgin A.T. Basic pharmacology and effects. Hallucinogens. A Forensic Drug Handbook 2003, 67. Elsevier Science, London, UK. R.R. Laing (Ed.).
4. Nichols D.E. Pharmacol. Ther. 2004, 101:131.
5. Fantegrossi W.E., Murnane K.S., Reissig C.J. Biochem. Pharmacol. 2008, 75:17.
6. Winter J.C. Psychopharmacology 2009, 203:251.
7. Keiser M.J., Setola V., Irwin J.J., Laggner C., Abbas A.I., Hufeisen S.J., Jensen N.H., Kuijer M.B., Matos R.C., Tran T.B., Whaley R., Glennon R.A., Hert J., Thomas K.L., Edwards D.D., Shoichet B.K., Roth B.L. Nature (London) 2009, 462:175.
8. Fontanilla D., Johannessen M., Hajipour A.R., Cozzi N.V., Jackson M.B., Ruoho A.E. Science (Washington, DC) 2009, 323:934.
9. Cozzi N.V., Gopalakrishnan A., Anderson L.L., Feih J.T., Shulgin A.T., Daley P.F., Ruoho A.E. J. Neural Transm. 2009, 116:1591.
10. Schultes R.E., Hofmann A. The Botany and Chemistry of Hallucinogens 1980, C.C. Thomas, Springfield, IL, USA.
11. Torres C.M., Repke D.B. Anadenanthera: Visionary Plant of Ancient South America 2006, The Haworth Press, Inc., Binghamton, NY, USA.
12. Griffiths R.R., Richards W.A., Johnson M.W., McCann U.D., Jesse R. J. Psychopharmacology 2008, 22:621.
13. Riba J., Valle M., Urbano G., Yritia M., Morte A., Barbanoj M.J. J. Pharmacol. Exp. Ther. 2003, 306:73.
14. Strassman R.J., Qualls C.R., Berg L.M. Biol. Psychiatry 1996, 39:784.
15. Hasler F., Grimberg U., Benz M.A., Huber T., Vollenweider F.X. Psychopharmacology 2004, 172:145.
16. Martins C.P.B., Freeman S., Alder J.F., Passie T., Brandt S.D. Trends Anal. Chem. 2010, 29:285.
17. Katagi M., Tsutsumi H., Miki A., Nakajima K., Tsuchihashi H. Jpn. J. Forensic Toxicol. 2002, 20:303.
18. Zimmerman M.M. Microgram J. 2003, 1:158.
19. Sarwar M., McDonald J.L. Microgram J. 2003, 1:177.
20. Brandt S.D., Freeman S., Fleet I.A., McGagh P., Alder J.F. Analyst (Cambridge, UK) 2005, 130:330.
21. Brandt S.D., Freeman S., Fleet I.A., Alder J.F. Analyst (Cambridge, UK) 2005, 130:1258.
22. Rodriguez-Cruz S.E. Microgram J. 2005, 3:107.
23. Spratley T.K., Hays P.A., Geer L.C., Cooper S.D., McKibben T.D. Microgram J. 2005, 3:54.
24. Kikura-Hanajiri R., Hayashi M., Saisho K., Goda Y. J. Chromatogr., B 2005, 825:29.
25. Tsujikawa K., Mohri H., Kuwayama K., Miyaguchi H., Iwata Y., Gohda A., Fukushima S., Inoue H., Kishi T. Forensic Sci. Int. 2006, 164:172.
26. Wang M.J., Liu J.T., Chen H.M., Lin J.J., Lin C.H. J. Chromatogr., A 2008, 1181:131.
27. Chen B.H., Liu J.T., Chen W.X., Chen H.M., Lin C.H. Talanta 2008, 74:512.
28. Takahashi M., Nagashima M., Suzuki J., Seto T., Yasuda I., Yoshida T. J. Health Sci. 2008, 54:89.
29. Takahashi M., Nagashima M., Suzuki J., Seto T., Yasuda I., Yoshida T. Talanta 2009, 77:1245.
30. Lin C.H., Kaneta T., Chen H.M., Chen W.X., Chang H.W., Liu J.T. Anal. Chem. 2008, 80:5755.
31. Brandt S.D., Martins C.P.B., Freeman S., Dempster N., Wainwright M., Riby P.G., Alder J.F. J. Pharm. Biomed. Anal. 2008, 47:207.
32. Brandt S.D., Martins C.P.B., Freeman S., Dempster N., Riby P.G., Gartz J., Alder J.F. Forensic Sci. Int. 2008, 178:162.
33. S.D. Brandt, S.A. Moore, S. Freeman, A.B. Kanu, Drug Test. Analysis (2010) (accepted for publication).
34. Pihlainen K., Sippola E., Kostiainen R. J. Chromatogr., A 2003, 994:93.
35. Lurie I.S. J. Chromatogr., A 2005, 1100:168.
36. Lurie I., Li L. J. Liq. Chromatogr. Related Technol. 2009, 32:2615.
37. Rodriguez-Cruz S.E. Microgram J. 2005, 3:175.
38. Laks S., Pelander A., Vuori E., Ali-Tolppa E., Sippola E., Ojanpera I. Anal. Chem. 2004, 76:7375.
39. Shimizu E., Watanabe H., Kojima T., Hagiwara H., Fujisaki M., Miyatake R., Hashimoto K., Iyo M. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31:288.
40. Huhn C., Pütz M., Martin N., Dahlenburg R., Pyell U. Electrophoresis 2005, 26:2391.
41. Brandt S.D., Freeman S., Fleet I.A., McGagh P., Alder J.F. Analyst (Cambridge, UK) 2004, 129:1047.
42. Martins C.P.B., Freeman S., Alder J.F., Brandt S.D. J. Chromatogr., A 2009, 1216:6119.
43. Anastos N., Barnett N.W., Pfeffer F.M., Lewis S.W. Sci. Justice 2006, 46:91.
44. Kagan M., Chlenov M., Melnikov S., Greenfield A., Gross J., Bernotas R.C. J. Chromatogr., A 2008, 1194:80.
45. Hsiao Y., Liu J.T., Lin C.H. Anal. Sci. 2009, 25:759.
46. Huikko K., Kotiaho T., Kostiainen R. Rapid Commun. Mass Spectrom. 2002, 16:1562.
47. Huikko K., Östman P., Grigoras K., Tuomikoski S., Tiainen V.M., Soininen A., Puolanne K., Manz A., Franssila S., Kostiainen R., Kotiaho T. Lab Chip 2003, 3:67.
48. Wang M.J., Tsai C.H., Hsu W.Y., Liu J.T., Lin C.H. J. Sep. Sci. 2009, 32:441.
49. Hugel J., Meyers J., Lankin D. Analysis of the hallucinogens. Hallucinogens. A Forensic Drug Handbook 2003, 191. Elsevier Science, London, UK. R.R. Laing (Ed.).
50. Albers C., Lehr M., Beike J., Kohler H., Brinkmann B. J. Pharm. Pharmacol. 2002, 54:1265.
51. Yamaguchi M., Saito T., Horiguchi Y., Ogawa K., Tsuchiya Y., Hishinuma K., Chikuma T., Makino Y., Hojo H. J. Health Sci. 2004, 50:600.
52. Kato N., Kojima T., Yoshiyagawa S., Ohta H., Toriba A., Nishimura H., Hayakawa K. J. Chromatogr., A 2007, 1145:229.
53. Anastos N., Barnett N.W., Lewis S.W., Gathergood N., Scammells P.J., Sims D.N. Talanta 2005, 67:354.
54. Sharma N., Jain S.K., Rastogi R.C. Spectrochim. Acta, Part A 2007, 66:171.
55. Rothchild R. Spectrosc. Lett. 2005, 38:521.
56. Tsumura Y., Mitome T., Kimoto S. Forensic Sci. Int. 2005, 155:158.